Related Experiment Videos
Brain choline acetyltransferase and mental function in Alzheimer disease
D S Baskin1, J L Browning, F J Pirozzolo
1Neurosurgery Section, Department of Surgery, Veterans Affairs Medical Center, Houston, Texas, USA. dbaskin@tmh.tmc.edu
Archives of Neurology
|September 17, 1999
Summary
Higher brain levels of choline acetyltransferase (ChAT) correlate with better cognitive function in Alzheimer disease (AD) patients. This suggests the cholinergic system
Area of Science:
- Neuroscience
- Neurology
- Biochemistry
Background:
- Alzheimer disease (AD) is a neurodegenerative disorder characterized by cognitive decline.
- The cholinergic system, involving acetylcholine, plays a crucial role in memory and cognition.
- Reduced levels of choline acetyltransferase (ChAT), an enzyme essential for acetylcholine synthesis, are implicated in AD pathogenesis.
Purpose of the Study:
- To investigate the association between brain choline acetyltransferase (ChAT) levels and neuropsychological function in patients with Alzheimer disease (AD).
Main Methods:
- A case series involving 8 patients with AD undergoing brain biopsy.
- Neuropsychological testing was performed within two weeks prior to biopsy.
- Choline acetyltransferase (ChAT) levels were quantified in fresh brain tissue obtained from biopsy specimens.
Main Results:
- A significant positive correlation was observed between brain ChAT levels and performance on the Mini-Mental State Examination.
- Higher ChAT levels were also positively correlated with scores on the Logical Memory subtest of the Wechsler Memory Scale.
Conclusions:
- The findings indicate that degeneration of the cholinergic system in vivo is associated with diminished cognitive function in Alzheimer disease (AD) patients.
- This highlights the importance of the cholinergic system in maintaining cognitive abilities in AD.